Đang chuẩn bị liên kết để tải về tài liệu:
Treatment with a combination of the ErbB (HER) family blocker afatinib and the IGF-IR inhibitor, NVP-AEW541 induces synergistic growth inhibition of human pancreatic cancer cells

Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ

Aberrant expression and activation of the IGF-IR have been reported in a variety of human cancers and have been associated with resistance to HER targeted therapy. In this study, we investigated the effect of simultaneous targeting of IGF-IR and HER (erbB) family, with NVP-AEW541 and afatinib, on proliferation of pancreatic cancer cells. |

TÀI LIỆU LIÊN QUAN

Study for determination of suitable pre treatment combination and dehydration temperature for broccoli florets

Research on clinical manifestations, correlative factors and evaluating the results of topical treatment of zona with He-Ne laser combination at Can Tho DermatoVenereology Hospital in 2021

Synergistic inhibition of tumor growth by combination treatment with drugs against different subpopulations of glioblastoma cells

Study protocol for an open-label, singlearm, phase Ib/II study of combination of toripalimab, nab-paclitaxel, and gemcitabine as the first-line treatment for patients with unresectable pancreatic ductal adenocarcinoma

Vascular disruptive agent OXi4503 and antiangiogenic agent Sunitinib combination treatment prolong survival of mice with CRC liver metastasis

The combination of ANT2 shRNA and hNIS radioiodine gene therapy increases CTL cytotoxic activity through the phenotypic modulation of cancer cells: Combination treatment with ANT2 shRNA and I-131

Effects of lisinopril and amlodipin in combination for the treatment of hypertension with pulse wave velocity VP plus 1000 meter

Prognostic model for overall survival that includes the combination of platelet count and neutrophil–lymphocyte ratio within the first six weeks of sunitinib treatment for metastatic renal cell carcinoma

Myocarditis as an immune-related adverse event following treatment with ipilimumab and nivolumab combination therapy for metastatic renal cell carcinoma: A case report

Perioperative treatment in resectable gastric cancer with spartalizumab in combination with fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT): A phase II study (GASPAR)